98 related articles for article (PubMed ID: 21139967)
1. Pancreatic Cancer: a rare tumor with a devastating health toll.
Fleshman J
Rare Tumors; 2010 Sep; 2(3):e52. PubMed ID: 21139967
[No Abstract] [Full Text] [Related]
2. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer.
Grimmig T; Moench R; Kreckel J; Haack S; Rueckert F; Rehder R; Tripathi S; Ribas C; Chandraker A; Germer CT; Gasser M; Waaga-Gasser AM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941651
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Karihtala P; Parkkila S; Saarnio J; Lehenkari PP; Karttunen TJ
APMIS; 2018 Nov; 126(11):852-863. PubMed ID: 30357962
[TBL] [Abstract][Full Text] [Related]
5. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
Leppänen J; Helminen O; Huhta H; Kauppila JH; Isohookana J; Haapasaari KM; Lehenkari P; Saarnio J; Karttunen TJ
Virchows Arch; 2017 Apr; 470(4):401-410. PubMed ID: 28191612
[TBL] [Abstract][Full Text] [Related]
6. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer.
Grimmig T; Matthes N; Hoeland K; Tripathi S; Chandraker A; Grimm M; Moench R; Moll EM; Friess H; Tsaur I; Blaheta RA; Germer CT; Waaga-Gasser AM; Gasser M
Int J Oncol; 2015 Sep; 47(3):857-66. PubMed ID: 26134824
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling.
Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S
Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
Lanki M; Seppänen H; Mustonen H; Hagström J; Haglund C
PLoS One; 2019; 14(7):e0219245. PubMed ID: 31314777
[TBL] [Abstract][Full Text] [Related]
9. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.
Cullis J; Siolas D; Avanzi A; Barui S; Maitra A; Bar-Sagi D
Cancer Immunol Res; 2017 Mar; 5(3):182-190. PubMed ID: 28108630
[TBL] [Abstract][Full Text] [Related]
10. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.
Santoni M; Andrikou K; Sotte V; Bittoni A; Lanese A; Pellei C; Piva F; Conti A; Nabissi M; Santoni G; Cascinu S
Cancer Treat Rev; 2015 Jul; 41(7):569-76. PubMed ID: 26036357
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine.
Ceccon G; Wollring M; Brunn A; Deckert M; Waldschmidt D; Fink GR; Galldiks N
Case Rep Oncol; 2020; 13(1):35-42. PubMed ID: 32095126
[TBL] [Abstract][Full Text] [Related]
12. Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.
Liu H; Li L; Chen H; Kong R; Pan S; Hu J; Wang Y; Li Y; Sun B
Oncotarget; 2017 Sep; 8(37):61674-61686. PubMed ID: 28977895
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy.
Hall WA; Goodman KA
Radiat Oncol; 2019 Jun; 14(1):114. PubMed ID: 31242912
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
Rosa R; Melisi D; Damiano V; Bianco R; Garofalo S; Gelardi T; Agrawal S; Di Nicolantonio F; Scarpa A; Bardelli A; Tortora G
Clin Cancer Res; 2011 Oct; 17(20):6531-41. PubMed ID: 21890455
[TBL] [Abstract][Full Text] [Related]
15. New insights into pancreatic cancer biology.
Hidalgo M
Ann Oncol; 2012 Sep; 23 Suppl 10():x135-8. PubMed ID: 22987949
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer.
Lee B; Gibbs P
J Pers Med; 2019 Apr; 9(2):. PubMed ID: 31035449
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl inhibits cell viability in human pancreatic cancer cell line and tumor growth in pancreatic cancer cell-transplanted mice.
Miao J; Wang L; Chen L; Yang T; Jin L; Lin L
Int J Clin Exp Med; 2015; 8(10):17684-93. PubMed ID: 26770358
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.
Bobrov E; Skobeleva N; Restifo D; Beglyarova N; Cai KQ; Handorf E; Campbell K; Proia DA; Khazak V; Golemis EA; Astsaturov I
Oncotarget; 2017 Jan; 8(3):4399-4409. PubMed ID: 27779106
[TBL] [Abstract][Full Text] [Related]
19. Role of cancer stem cells in pancreatic ductal adenocarcinoma.
Sergeant G; Vankelecom H; Gremeaux L; Topal B
Nat Rev Clin Oncol; 2009 Oct; 6(10):580-6. PubMed ID: 19687789
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1.
Chen X; Cheng F; Liu Y; Zhang L; Song L; Cai X; You T; Fan X; Wang D; Gong A; Zhu H
EBioMedicine; 2019 Feb; 40():135-150. PubMed ID: 30679086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
